CompanyDrug

Immune-Onc Therapeutics’ IO-202 Earns Orphan Drug Designation for CMML from US FDA

CompanyDrug

Innovent Biologics’ Tyvyt Receives Marketing Approval for Multiple Indications in Macau

CompanyMedical Device

Zylox-Tonbridge Receives UAE Approval for Five Medical Devices, Expands Middle East Presence

CompanyDrug

MSD’s Belzutifan and Sperogenix’s Vamorolone Targeted for Priority Review by China’s CDE

Policy / Regulatory

CDE Opens Consultation on 79th Batch of Generic Drug Reference Preparations

CompanyDrug

Zhongsheng Pharmaceutical Initiates Phase II Trials for Polypeptide Drug RAY1225 in Diabetes and Obesity

CompanyDeals

AstraZeneca Secures Shareholder Approval for $1 Billion Acquisition of Gracell Biotechnologies

Policy / Regulatory

FDA Issues Warning Letter to Sichuan Deebio for cGMP Violations in API Manufacturing

CompanyDrug

Bayer Advances BAY3018250 into Phase II Trial Following Successful Phase I Completion

CompanyDrug

BMS Seeks FDA Priority Review for Krazati in Advanced Colorectal Cancer

CompanyDrug

WuXi ATU’s Philadelphia Facility Approved for Amtagvi Production Following FDA Nod

CompanyDeals

HitGen’s Vernalis Partners with Hox Therapeutics to Develop Novel Cancer Inhibitors